Resorbable Phenolic Polymers for Medical Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional medical polymers derived from tyrosine, such as polyarylates and polycarbonates, exhibit slow degradation and resorption rates, often taking more than a year to completely resorb, which can lead to residual material causing inflammation, scarring, and complications like thrombosis in medical implants.
Innovation Solution
Modifying the polymers to increase the water solubility of diphenol or diacid monomer units, incorporating pendant carboxylic acid groups, and using specific monomer structures to enhance hydrolytic degradation and resorption within one year while maintaining mechanical robustness and drug release capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If conventional tyrosine-derived polymers (polyarylates, polycarbonates) are used, then mechanical strength and structural stability are maintained, but resorption rate is slow (exceeding 1 year)
Solution Approach 1:
The patent modifies the chemical structure of diphenol monomer units by introducing carboxylic acid groups at positions 2, 3, 4, or 5 of the aromatic ring. This parameter change in molecular structure increases hydrophilicity and water solubility, accelerating hydrolytic degradation and resorption to within one year while preserving mechanical properties through controlled substitution patterns
Solution Approach 2:
The invention creates composite polymer structures combining modified diphenol units with ester-protected carboxylic acid side chains. The ester groups provide initial mechanical strength and structural stability, while the carboxylic acid moieties promote hydrolytic degradation, achieving a balance between strength and resorption rate
2Object-affected harmful factors
If complete resorption within one year is achieved through monomer modification, then residual material complications are reduced, but polymer synthesis complexity increases
Solution Approach 1:
The patent introduces carboxylic acid groups at specific local positions (2, 3, 4, or 5) of the diphenol aromatic ring rather than uniform modification throughout the molecule. This localized structural change selectively enhances hydrophilicity and resorption rate while maintaining the core mechanical properties of the polymer backbone, reducing residual material complications without requiring complete redesign of the polymer structure
Solution Approach 2:
The invention segments the diphenol monomer structure into distinct functional regions: the core aromatic ring providing mechanical stability and specific positions (2, 3, 4, 5) modified with carboxylic acid groups for enhanced resorption. This segmentation allows independent optimization of mechanical strength and degradation rate, simplifying the overall design approach
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified polymers achieve complete resorption within one year, ensuring biocompatibility and reducing the risk of residual material-related complications, with adaptable properties for both hydrophobic and hydrophilic drugs, enhancing the versatility and utility of medical device coatings.
Implementation Method 1
These polymers are hydrolytically degradable and resorb within one year
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention provides biocompatible resorbable polymers, comprising monomer units having formula (I), formula (II), formula (III) or formula (IV). The polymers degrade over time when implanted in the body, and are useful as components of implantable medical devices.